Background
The company was recently approved to manufacture the active ingredients in Velcade®, Vidaza® and Clolar®. These manufacturing approvals were for ”fast-tracked” drugs and required significantly compressed development program timelines. All three drugs were approved less than one year from filing–a testament to our experience, expertise and dedication to excellence.
Background 1 | 2